Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C403051
http://purl.bioontology.org/ontology/MESH/C403051
|
|---|---|
| Preferred Name | LF 16-0687 |
| Synonyms |
LF16-0687Ms
Anatibant
LF16-0687
1-((2,4-dichloro-3-(((2,4-dimethylquinolin-8-yl)oxy) methyl)phenyl)sulfonyl)-N-(3-((4-(aminoimethyl) phenyl) carbonylamino)propyl)-2(S)-pyrrolidinecarboxamide
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | LF16-0687Ms
Anatibant
LF16-0687
1-((2,4-dichloro-3-(((2,4-dimethylquinolin-8-yl)oxy) methyl)phenyl)sulfonyl)-N-(3-((4-(aminoimethyl) phenyl) carbonylamino)propyl)-2(S)-pyrrolidinecarboxamide
|
|---|---|
| prefLabel | LF 16-0687
|
| Scope Statement | a potent non-peptide bradykinin B2 receptor antagonist; structure in first source
|
| type | |
| isa | |
| PA | D065168
|
| tui |
T109
T123
T121
|
| HM | D011804
|
| SC | 1
|
| TERMUI |
T672782
T405434
T672783
T405433
T405435
|
| TH |
NLM (2000)
USAN (1999)
INN (19XX)
NLM (2006)
FDA SRS (2015)
|
| SRC | Immunopharmacology 1999 Sep;43(2-3):187-94
|
| MMR | 20141017
|
| notation | C403051
|
| Semantic type UMLS property | |
| RR | CLO4JRD21F
|
| cui |
C2741863
C2718119
C0911423
C2741862
|
| MeSH Frequency | 32
|
| LT | TRD
|
| DSC | 20000121
|
| Inverse of RB |
CLO4JRD21F
0
|
| Mapped to | |
| MDA | 20000121
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |